Moloney Securities Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$262K Sell
2,367
-164
-6% -$18.2K 0.03% 391
2025
Q1
$284K Sell
2,531
-22,629
-90% -$2.54M 0.04% 360
2024
Q4
$2.32M Sell
25,160
-815
-3% -$75.3K 0.31% 80
2024
Q3
$2.18M Buy
25,975
+1,326
+5% +$111K 0.29% 84
2024
Q2
$1.69M Buy
24,649
+5,960
+32% +$409K 0.24% 97
2024
Q1
$1.37M Sell
18,689
-537
-3% -$39.3K 0.21% 124
2023
Q4
$1.56M Sell
19,226
-344
-2% -$27.9K 0.25% 97
2023
Q3
$1.47M Sell
19,570
-298
-1% -$22.3K 0.26% 91
2023
Q2
$1.53M Buy
19,868
+1,378
+7% +$106K 0.27% 91
2023
Q1
$1.53M Sell
18,490
-2,788
-13% -$231K 0.29% 94
2022
Q4
$1.83M Sell
21,278
-552
-3% -$47.4K 0.4% 66
2022
Q3
$1.35M Sell
21,830
-345
-2% -$21.3K 0.33% 80
2022
Q2
$1.37M Sell
22,175
-99
-0.4% -$6.12K 0.32% 85
2022
Q1
$1.32M Buy
22,274
+1,449
+7% +$86.1K 0.26% 115
2021
Q4
$1.51M Buy
20,825
+1,018
+5% +$73.9K 0.26% 96
2021
Q3
$1.38M Buy
19,807
+781
+4% +$54.5K 0.25% 106
2021
Q2
$1.31M Buy
19,026
+202
+1% +$13.9K 0.24% 111
2021
Q1
$1.22M Sell
18,824
-1,406
-7% -$90.9K 0.24% 114
2020
Q4
$1.18M Sell
20,230
-1,249
-6% -$72.8K 0.26% 102
2020
Q3
$1.36M Buy
21,479
+263
+1% +$16.6K 0.36% 82
2020
Q2
$1.63M Sell
21,216
-1,311
-6% -$101K 0.47% 74
2020
Q1
$1.68M Buy
22,527
+622
+3% +$46.5K 0.6% 55
2019
Q4
$1.42M Buy
21,905
+17,633
+413% +$1.15M 0.44% 63
2019
Q3
$271K Sell
4,272
-280
-6% -$17.8K 0.09% 249
2019
Q2
$308K Sell
4,552
-611
-12% -$41.3K 0.1% 218
2019
Q1
$336K Buy
5,163
+470
+10% +$30.6K 0.12% 203
2018
Q4
$294K Buy
4,693
+285
+6% +$17.9K 0.12% 197
2018
Q3
$340K Buy
4,408
+1
+0% +$77 0.12% 194
2018
Q2
$312K Sell
4,407
-52
-1% -$3.68K 0.12% 202
2018
Q1
$336K Buy
4,459
+232
+5% +$17.5K 0.14% 189
2017
Q4
$303K Hold
4,227
0.13% 192
2017
Q3
$342K Hold
4,227
0.15% 173
2017
Q2
$299K Sell
4,227
-728
-15% -$51.5K 0.15% 179
2017
Q1
$337K Sell
4,955
-1,428
-22% -$97.1K 0.17% 161
2016
Q4
$457K Buy
+6,383
New +$457K 0.28% 116